Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-3-Oxocyclopentanecarboxylic acid, commonly known as levulinic acid or 4-oxopentanoic acid, is an organic compound with the chemical formula C5H8O3. It is a white crystalline solid that is soluble in water and polar organic solvents. This renewable, plant-based substance is typically manufactured from cellulose, a biomass material. As a valuable platform chemical, it has several potential applications across various industries.

71830-06-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 71830-06-3 Structure
  • Basic information

    1. Product Name: (S)-3-Oxocyclopentanecarboxylic acid
    2. Synonyms: (S)-3-Oxocyclopentanecarboxylic acid;(1S)-3-oxocyclopentane-1-carboxylic acid
    3. CAS NO:71830-06-3
    4. Molecular Formula: C6H8O3
    5. Molecular Weight: 128.12592
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 71830-06-3.mol
  • Chemical Properties

    1. Melting Point: 64-65 °C(Solv: ethyl ether (60-29-7); hexane (110-54-3))
    2. Boiling Point: 300.6±35.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.314±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 4.62±0.20(Predicted)
    10. CAS DataBase Reference: (S)-3-Oxocyclopentanecarboxylic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: (S)-3-Oxocyclopentanecarboxylic acid(71830-06-3)
    12. EPA Substance Registry System: (S)-3-Oxocyclopentanecarboxylic acid(71830-06-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 71830-06-3(Hazardous Substances Data)

71830-06-3 Usage

Uses

Used in Chemical Production:
(S)-3-Oxocyclopentanecarboxylic acid is used as a key intermediate in the production of fuel additives, resins, plasticizers, and pharmaceuticals. Its versatility as a platform chemical makes it a valuable component in the synthesis of various compounds.
Used in Cancer Treatment:
(S)-3-Oxocyclopentanecarboxylic acid is used as a selective cytotoxic agent for cancer treatment. Its properties suggest that it can be employed in the development of new therapeutic strategies, particularly for targeting cancer cells while minimizing harm to healthy cells.
Used in Renewable Energy:
(S)-3-Oxocyclopentanecarboxylic acid is used as a renewable resource in the production of biofuels and other energy-related applications. Its plant-based origin and potential for large-scale production from biomass make it an attractive option for sustainable energy solutions.
Challenges in Industrial Production:
Despite its potential applications, the large-scale industrial production of (S)-3-Oxocyclopentanecarboxylic acid remains a challenge due to high production costs and low yields. Efforts are being made to improve the efficiency and cost-effectiveness of its production processes to make it a more viable option for widespread use.

Check Digit Verification of cas no

The CAS Registry Mumber 71830-06-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,8,3 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 71830-06:
(7*7)+(6*1)+(5*8)+(4*3)+(3*0)+(2*0)+(1*6)=113
113 % 10 = 3
So 71830-06-3 is a valid CAS Registry Number.

71830-06-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-(S)-3-oxocyclopentanecarboxylic acid

1.2 Other means of identification

Product number -
Other names (S)-3-Oxocyclopentanecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71830-06-3 SDS

71830-06-3Relevant articles and documents

Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1 S,3 S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115)

Lee, Hyunbeom,Doud, Emma H.,Wu, Rui,Sanishvili, Ruslan,Juncosa, Jose I.,Liu, Dali,Kelleher, Neil L.,Silverman, Richard B.

, p. 2628 - 2640 (2015)

γ-Aminobutyric acid aminotransferase (GABA-AT) is a pyridoxal 5′-phosphate (PLP)-dependent enzyme that degrades GABA, the principal inhibitory neurotransmitter in mammalian cells. When the concentration of GABA falls below a threshold level, convulsions can occur. Inhibition of GABA-AT raises GABA levels in the brain, which can terminate seizures as well as have potential therapeutic applications in treating other neurological disorders, including drug addiction. Among the analogues that we previously developed, (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115) showed 187 times greater potency than that of vigabatrin, a known inactivator of GABA-AT and approved drug (Sabril) for the treatment of infantile spasms and refractory adult epilepsy. Recently, CPP-115 was shown to have no adverse effects in a Phase I clinical trial. Here we report a novel inactivation mechanism for CPP-115, a mechanism-based inactivator that undergoes GABA-AT-catalyzed hydrolysis of the difluoromethylene group to a carboxylic acid with concomitant loss of two fluoride ions and coenzyme conversion to pyridoxamine 5′-phosphate (PMP). The partition ratio for CPP-115 with GABA-AT is about 2000, releasing cyclopentanone-2,4-dicarboxylate (22) and two other precursors of this compound (20 and 21). Time-dependent inactivation occurs by a conformational change induced by the formation of the aldimine of 4-aminocyclopentane-1,3-dicarboxylic acid and PMP (20), which disrupts an electrostatic interaction between Glu270 and Arg445 to form an electrostatic interaction between Arg445 and the newly formed carboxylate produced by hydrolysis of the difluoromethylene group in CPP-115, resulting in a noncovalent, tightly bound complex. This represents a novel mechanism for inactivation of GABA-AT and a new approach for the design of mechanism-based inactivators in general.

Nitrilase activity screening on structurally diverse substrates: Providing biocatalytic tools for organic synthesis

Vergne-Vaxelaire, Carine,Bordier, Franck,Fossey, Aurelie,Besnard-Gonnet, Marielle,Debard, Adrien,Mariage, Aline,Pellouin, Virginie,Perret, Alain,Petit, Jean-Louis,Stam, Mark,Salanoubat, Marcel,Weissenbach, Jean,De Berardinis, Veronique,Zaparucha, Anne

, p. 1763 - 1779 (2013/07/19)

A high-throughput screening of candidate nitrilases against 25 structurally diverse substrates allowed us to create a wide collection of 125 experimentally validated nitrilases. The enzymes were selected by genomic approach from 700 diverse prokaryotic species and one metagenome as representative of the nitrilase family diversity. The enzymatic screening of this collection expands the biocatalytic toolbox for chemical synthesis by providing a large number of tested nitrilases with their assigned substrates. Three examples illustrate the synthetic potential of our enzyme collection. The syntheses of carboxylic acid building blocks, a β-substituted phenylpropanoic acid, a cyclic γ-keto carboxylic acid and a mononitrile monocarboxylic acid, were achieved from the corresponding nitrile substrates, using three new nitrilases (two from Sphingomonas wittichii and one from Syntrophobacter fumaroxidans). Improvements of nitrilase activities through the optimization of reaction parameters and the preparative biocatalytic synthesis are presented for these three examples. Copyright

Asymmetric synthesis and structure-activity relationship of the four stereoisomers of the antibiotic amidinomycin part 1: The synthesis

Sung, Sun-Young,Frahm, August Wilhelm

, p. 291 - 300 (2007/10/03)

The natural amidinomycin ((1R, 3S)-14) and its three stereoisomers are synthesized from homochiral 3-oxocyclopentanecarboxylic acids (1a) by asymmetric methods, which are based on an asymmetric reductive amination to produce methyl cis-N-(1-phenylethyl)-3-aminocyclo-pentanecarboxylates (3b) via optically active methyl N-(1-phenylethyl)-3-iminocyclopentane- carboxylates (2b) for the cis-isomers of 14. Optically pure trans-3- aminocyclopentane-carboxylic acids (4a) are obtained from the homochiral keto acids 1a via asymmetric reductive amination of 3- hydroxyiminocyclopentanecarboxylic acids (5a) and lead to the trans-isomers of 14.

CHEMOENZYMATIC SYNTHESIS OF CONFORMATIONALLY RIGID GLUTAMIC ACID ANALOGUES

Trigalo, F.,Buisson, D.,Azerad, R.

, p. 6109 - 6112 (2007/10/02)

All stereomers of cyclohexane cyclopentane-derived analogues of glutamic acid have been synthesized from the corresponding 3-keto-cycloalkyl carboxylic acid esters by a combination of microbial steps and standard chemical methods.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 71830-06-3